calendar
4,447 catalysts · 3,126 8k filing · 576 earnings · 249 grant · 179 approval · 172 phase 2 completion · 133 drug shortage
next 91 dayslessmore
MonWedFri
4,447 catalysts · 3,126 8k filing · 576 earnings · 249 grant · 179 approval · 172 phase 2 completion · 133 drug shortage
Sponsor: SCIENTURE. Form: SPRAY. Route: NASAL
Sponsor: APOTEX. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL
Product code: OAS. Advisory committee: Radiology. Type: Special
Product code: POV. Advisory committee: Hematology. Type: Traditional
Product code: QWJ. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: NHA. Advisory committee: Dental. Type: Special
Product code: GXN. Advisory committee: Neurology. Type: Traditional
Product code: QJP. Advisory committee: Cardiovascular. Type: Special
Product code: JXI. Advisory committee: Neurology. Type: Traditional
Product code: OLO. Advisory committee: Neurology. Type: Special
Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional
Product code: FGB. Advisory committee: Gastroenterology, Urology. Type: Traditional
Product code: EIH. Advisory committee: Dental. Type: Traditional
Product code: IYO. Advisory committee: Radiology. Type: Traditional
Supplement type: Normal 180 Day Track No User Fee. Product code: MJO. Advisory committee: OR. Decision: APPR
Supplement type: 30-Day Notice. Product code: MDP. Advisory committee: GU. Decision: OK30
Supplement type: 30-Day Notice. Product code: QZK. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: LWR. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: MFE. Advisory committee: NE. Decision: OK30
Supplement type: 30-Day Notice. Product code: MCM. Advisory committee: EN. Decision: OK30
Supplement type: 30-Day Notice. Product code: NZK. Advisory committee: NE. Decision: OK30
Supplement type: 30-Day Notice. Product code: LPM. Advisory committee: OP. Decision: OK30
Supplement type: 30-Day Notice. Product code: MOZ. Advisory committee: OR. Decision: OK30
Supplement type: 135 Review Track For 30-Day Notice. Product code: NPV. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: NPT. Advisory committee: CV. Decision: APPR
Supplement type: Real-Time Process. Product code: NPV. Advisory committee: CV. Decision: APPR
Supplement type: 30-Day Notice. Product code: MCX. Advisory committee: CV. Decision: OK30
Supplement type: 30-Day Notice. Product code: OAD. Advisory committee: CV. Decision: OK30
AI grant. $470,978. PI: Benjamin Robert Lundgren
ES grant. $156,500. PI: YUSUKE MARIKAWA
NR grant. $175,280. PI: Jillian Pintye
AI grant. $417,567. PI: John Schneider
AI grant. $192,500. PI: YUYING LIANG
CA grant. $47,827. PI: Paarth Bhupendra Dodhiawala
AT grant. $676,491. PI: Antonia Zaferiou
AT grant. $550,030. PI: Lauren M Hablitz
AI grant. $893,459. PI: DAVID Branch MOODY
HG grant. $705,019. PI: Eu Gene Chin
AI grant. $194,904. PI: Eric Isaac Elliott
AI grant. $954,603. PI: Raymond Felix Schinazi
AI grant. $183,439. PI: Ana A Weil
HD grant. $77,902. PI: Gabrielle Rose Rinne
Aller-C Dietary Supplement
Sponsor: JANSSEN PHARMS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: MICRO LABS. Form: TABLET. Route: ORAL
Sponsor: TIANJIN TIANYAO. Form: TABLET. Route: ORAL